상세 보기
A phase 1/2a trial of amsulostat, a novel pan-lysyl oxidase inhibitor, in patients with advanced myelofibrosis as an add-on to ruxolitinib treatment for up to 52 weeks
- Baker, Ross;
- Chen, Chih-Cheng;
- Chen, Tsai-Yun;
- Cheung, Stanley;
- Hsiao, Hui-Hua;
- ... Lee, Jae Hoon;
- 외 12명
Citations
WEB OF SCIENCE
1- 제목
- A phase 1/2a trial of amsulostat, a novel pan-lysyl oxidase inhibitor, in patients with advanced myelofibrosis as an add-on to ruxolitinib treatment for up to 52 weeks
- 저자
- Baker, Ross; Chen, Chih-Cheng; Chen, Tsai-Yun; Cheung, Stanley; Hsiao, Hui-Hua; Lee, Jae Hoon; Lee, Ji Yun; Lee, Sung-Eun; Lee, Won Sik; Masarova, Lucia; Tan, Peter; Tan, Shuhying; Vachhani, Pankit; Watson, Anne Marie; Wu, Shang-Ju; Baskar, Jana; Leadbetter, Joanna; Jarolimek, Wolfgang
- 발행일
- 2025-11
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 146
- 페이지
- 2027 ~ 2028
- 언어
- ENG
- 출판사
- ELSEVIER
- 발행국가
- 네덜란드
- 분량
- 2 페이지
- ISSN
- E 1528-0020
P 0006-4971